Rigel Pharma (RIGL) Misses Q1 EPS by 4c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $45.73 +2.81%
EPS Growth %: -34.9%
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: -34.9%
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) reported Q1 EPS of ($0.40), $0.04 worse than the analyst estimate of ($0.36).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- Macy's (M) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY Guidance
- High Tide Inc. (HITI) Tops Q2 EPS by 11c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
